PEP-Therapy
0 followers
‌
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.
Industries
Headquarters
Employees
Links
Org chart
Antoine Prestat
Co-founder & CEO
Antoine Prestat
Collapse
Jennifer Sengenès
Head of Strategy & Development
Laura Dadon
Head of Regulatory Affairs & Development
Michele Marzola
Director and Lead Investor
